Protective and antifungal properties of Nanodisk-Amphotericin B over commercially available Amphotericin B
Objective: Amphotericin B (AMB), a potent antifungal agent, has been employed as topical and systemic therapy for sinonasal fungal infections. A novel formulation of nanodisc (ND) containing super aggregated AMB (ND-AMB) for the treatment of fungal infections has been recently developed to provide g...
Main Authors: | Do-Yeon Cho, Kyle J. Hoffman, Gobind S. Gill, Dong-Jin Lim, Daniel Skinner, Calvin Mackey, Steven M. Rowe, Bradford A. Woodworth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-03-01
|
Series: | World Journal of Otorhinolaryngology-Head and Neck Surgery |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2095881117300082 |
Similar Items
-
Encochleated Amphotericin B: Is the Oral Availability of Amphotericin B Finally Reached?
by: Maria Aigner, et al.
Published: (2020-05-01) -
Amphotericin B: an antifungal drug in nanoformulations for the treatment of paracoccidioidomycosis
by: Mônica Pereira Garcia, et al.
Published: (2013-12-01) -
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy
by: Célia Faustino, et al.
Published: (2020-01-01) -
An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased Safety.
by: Armando Antillón, et al.
Published: (2016-01-01) -
Is 24 hours infusion of Amphotericin B deoxycholate as good as liposomal Amphotericin B?
by: Swiss Medical Weekly
Published: (2002-08-01)